Open Mobile Menu OVERVIEW Symbol ALIM Last 5.81 % Change 2.47% Volume 13,474 Shares 6.92 million Market Cap 40.23 million Price Delayed by 20 minutes Alimera is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. Tear Sheet IR Contacts Subscribe to News Alerts RSS Feed COMPANY PROFILE 6120 Windward Parkway, Suite 290 Alpharetta, GA 30005 1 (844) 445-8843 (678) 990 5744 info@alimerasciences.com LEADERSHIP View Management Team RECENT NEWS & FILINGS NEWS NOV 9, 2021 Alimera Sciences to Participate in Upcoming November 2021 Investor Conferences OCT 28, 2021 Alimera Sciences Announces Third Quarter 2021 Financial Results OCT 21, 2021 Alimera Sciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021, and Provide Corporate Update OCT 13, 2021 Recent 24-Month Real-World PALADIN Data Demonstrate the Ability of ILUVIEN® to Significantly Reduce Treatment Burden in Patients with Diabetic Macular Edema View All News Articles FILINGS View All Filings Alimera Sciences New Day Trial Initiation Presentation Alimera Sciences New Day Study Webcast Corporate Presentation Quarterly Report INVESTOR RELATIONS Cindy Rizzo, CORE IR 516 222 2560 ir@alimerasciences.com TRANSFER AGENT AST Financial, Bryan Anderson, Relationship Manager banderson@astfinancial.com AUDITORS Grant Thornton LLP Joseph Heatherly, Partner, Joseph.Heatherly@us.gt.com CORPORATE COUNSEL Charles Vaughn, Nelson Mullins (404) 322-6189 charles.vaughn@nelsonmullins.com CLICK HERE TO SUBSCRIBE TO IR NEWS AND FILING ALERTS You can opt out at any time. We do not share or sell your info. Alimera Sciences is a publicly traded pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases. Facebook LinkedIn Twitter Alimera Sciences Corporate Offices 6120 Windward Parkway Suite 290 Alpharetta, GA 30005 Phone: +1 (678) 990-5740 toll-free +1 (844) 445-8843 Twitter: @alimerasciences European Website Copyright 2021 Alimera Sciences. This site intended for U.S. residents only. | Legal Statement | Privacy Policy | Privacy Shield Policy | Contact Us × HOME ABOUT PRODUCTS NEWS INVESTORS CONTACT

Open Mobile Menu PRESS RELEASES Alimera Sciences is a publicly traded pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases. Facebook LinkedIn Twitter Alimera Sciences Corporate Offices 6120 Windward Parkway Suite 290 Alpharetta, GA 30005 Phone: +1 (678) 990-5740 toll-free +1 (844) 445-8843 Twitter: @alimerasciences European Website Copyright 2021 Alimera Sciences. This site intended for U.S. residents only. | Legal Statement | Privacy Policy | Privacy Shield Policy | Contact Us ×